New drug aims to ease social struggles in autism
NCT ID NCT05081245
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an experimental drug called ML-004 in 168 adolescents and adults with autism spectrum disorder to see if it could improve social communication skills. Participants were randomly assigned to receive either the drug or a placebo for several weeks. The main goal was to measure changes in social communication using a caregiver questionnaire.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTISM SPECTRUM DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
APG Research, LLC
Orlando, Florida, 32803, United States
-
Abba Medical Group
Miami, Florida, 33176, United States
-
BioBehavioral Research of Austin
Austin, Texas, 78759, United States
-
Brain and Mind Centre
Camperdown, New South Wales, 2050, Australia
-
Cedar Clinical Research
Draper, Utah, 84020, United States
-
Center for Autism and the Developing Brain, New York State Psychiatric Institute
White Plains, New York, 10605, United States
-
Children's National Health System - The Children's Research Institute (CRI)
Washington D.C., District of Columbia, 20010, United States
-
Cortica
San Rafael, California, 94903, United States
-
Cortica Healthcare
Glendale, California, 91203, United States
-
Family Psychiatry of The Woodlands
The Woodlands, Texas, 77381, United States
-
Harmonex Neuroscience Research
Dothan, Alabama, 36303, United States
-
Holland Bloorview Kids Rehabilitation Hospital
Toronto, Ontario, M4G 1R8, Canada
-
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
-
Lawson Health Research Institute/ London Health Sciences Centre
London, Ontario, N6A 5W9, Canada
-
NRC Research Institute
Orange, California, 92868, United States
-
Nathan Kline Institute for Psychiatric Research
Orangeburg, New York, 10962, United States
-
Neurobehavioral Medicine Group
Bloomfield Hills, Michigan, 48302, United States
-
OCT Research ULC (dba Okanagan Clinical Trials)
Kelowna, British Columbia, V1Y 1Z9, Canada
-
Ohio State University Nisonger Center
Columbus, Ohio, 43210, United States
-
Red Oak Psychiatry Associates, PA
Houston, Texas, 77090, United States
-
Richmond Behavioral Associates
Staten Island, New York, 10314, United States
-
Road Runner Research, Ltd.
San Antonio, Texas, 78249, United States
-
Southwest Autism Research & Resource Center, Clinical Research
Phoenix, Arizona, 85006, United States
-
Suburban Research Associates
Media, Pennsylvania, 19063, United States
-
The Royal Children's Hospital, Murdoch Children's Research Institute
Parkville, Victoria, 3052, Australia
-
University of Missouri, Thompson Center for Autism & Neurodevelopmental Disorders
Columbia, Missouri, 65211, United States
-
University of South Florida Psychiatry and Behavioral Neurosciences
Tampa, Florida, 33613, United States
-
Virginia Commonwealth University
Richmond, Virginia, 23220, United States
-
Yale Child Study Center
New Haven, Connecticut, 06519, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light-Up training pods may sharpen reflexes in autistic teen athletes
- Could online coaching for parents boost autistic Children's social skills?
- Can a new curriculum help autistic adults navigate romance?
- Could a phone app help parents of kids with special needs thrive?
- Can a parent support group help teens with both autism and anorexia?
- Could a Self-Help guide transform parenting stress for families of kids with NDD?